Erik Anders Kronström
Chief Operating Officer bij INFANT BACTERIAL THERAPEUTICS AB
Vermogen: 83 751 $ op 31-03-2024
Actieve functies van Erik Anders Kronström
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
INFANT BACTERIAL THERAPEUTICS AB | Chief Operating Officer | 01-01-2018 | - |
Chief Tech/Sci/R&D Officer | 20-10-2014 | 01-01-2018 |
Loopbaan van Erik Anders Kronström
Eerdere bekende functies van Erik Anders Kronström
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Chief Executive Officer | - | - |
Opleiding van Erik Anders Kronström
Warwick Business School | Masters Business Admin |
Royal Institute of Technology | Graduate Degree |
Statistieken
Internationaal
Zweden | 3 |
Verenigd Koninkrijk | 2 |
Noorwegen | 2 |
Operationeel
Chief Executive Officer | 1 |
Graduate Degree | 1 |
Masters Business Admin | 1 |
Sectoraal
Consumer Services | 3 |
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
INFANT BACTERIAL THERAPEUTICS AB | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Health Technology |